Introduction: Type 2diabetes is one of the chronic and serious conditions that occur commonly. Metformin (MT) is an essential drug
used to control symptoms of type 2 diabetes. It is usually taken in combination with other medications to lower blood sugar levels.
Nanoparticles of the plant Costus speciosus (NPC) decreased the concentrations of blood glucose in the sera of experimental animals
with diabetes type 2. Aim: This study aimed to examine the potential additive antidiabetic impact of oral NPC and their preliminary
mechanism of action when added in combination with MT in type 2 diabetic rats, compared to MT monotherapy. Methods: Type 2
diabetes was induced in 30 male Wistar rats using high-fat diet and streptozotocin. The rats were separated into 5 groups and
treated orally with MT, NPC, or MT and NPC. Results: The results showed that NPC reduced blood sugar levels, increased insulin
secretion, decreased lipid peroxidation, downregulated gene expression of caspase-3, and improved the pathology of pancreatic
beta cells. The use of the NPC and MT combination showed a marked improvement in body weight and insulin secretion, and a
distinct reduction in oxidative stress and beta-cell damage. Conclusion: The use of NPC with MT is an effective treatment regimen in
managing unfavourable symptoms of experimentally induced diabetes type 2.
Keywords: Nanoparticles Costus speciosus, type 2 diabetes, metformin, streptozotocin, insulin, oxidative stress, caspase-3